Free Trial

Northstar Financial Companies Inc. Invests $331,000 in Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

Northstar Financial Companies Inc. purchased a new position in shares of Colgate-Palmolive (NYSE:CL - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 3,640 shares of the company's stock, valued at approximately $331,000.

A number of other institutional investors and hedge funds have also made changes to their positions in CL. Mattson Financial Services LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth about $264,000. Wood Tarver Financial Group LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth about $48,000. GHE LLC grew its position in Colgate-Palmolive by 1.7% during the fourth quarter. GHE LLC now owns 21,288 shares of the company's stock worth $1,935,000 after buying an additional 350 shares during the period. Menard Financial Group LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth about $102,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Colgate-Palmolive during the fourth quarter worth about $97,950,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 0.8%

Shares of Colgate-Palmolive stock traded up $0.72 during trading hours on Friday, hitting $93.02. The company's stock had a trading volume of 6,317,272 shares, compared to its average volume of 4,698,625. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The business has a fifty day moving average of $92.02 and a 200 day moving average of $91.27. The company has a market capitalization of $75.39 billion, a PE ratio of 26.43, a P/E/G ratio of 4.20 and a beta of 0.39. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. The business had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business's revenue was down 3.0% on a year-over-year basis. During the same period last year, the business earned $0.86 EPS. As a group, equities analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive declared that its board has initiated a share buyback program on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to repurchase up to 6.8% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's board believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th were paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.24%. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date was Thursday, April 17th. Colgate-Palmolive's dividend payout ratio is 58.76%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Stifel Nicolaus lowered their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a research report on Monday, February 3rd. Piper Sandler reduced their price target on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a report on Monday, March 31st. Wall Street Zen downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a report on Monday, April 28th. Finally, UBS Group upped their price target on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a report on Thursday, April 17th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and ten have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $102.12.

View Our Latest Analysis on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines